On December 29, 2023 Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) reported that as an inducement to entering into employment with the Company, on December 28, 2023, the Company’s Board of Directors approved "inducement" grants to 32 new employees under Rule 5635(c)(4) of the NASDAQ Listing Rules (Press release, Arrowhead Pharmaceuticals, DEC 29, 2023, View Source [SID1234638840]). The grants entitle employees, in aggregate, to receive up to 53,700 restricted stock units. The grants are outside the Company’s stockholder-approved equity incentive plans and vest annually over four years.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!